Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15202906rdf:typepubmed:Citationlld:pubmed
pubmed-article:15202906lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:15202906lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:15202906lifeskim:mentionsumls-concept:C0332256lld:lifeskim
pubmed-article:15202906pubmed:issue13lld:pubmed
pubmed-article:15202906pubmed:dateCreated2004-6-18lld:pubmed
pubmed-article:15202906pubmed:abstractTextEnantiomerically pure (-)-(1R,4R,5R,6S)- and (+)-(1S,4S,5S,6R)-7-(tert-butoxycarbonyl)-5,6-exo-isopropylidenedioxy-7-azabicyclo[2.2.1]hept-2-one ((-)-3 and (+)-3) have been obtained from the Diels-Alder adduct of N-(tert-butoxycarbonyl)pyrrole and 2-bromo-1-(p-toluenesulfonyl)acetylene, including the Alexakis optical resolution of ketone (+/-)-3 via formation of cyclic aminals with (1R,2R)-diphenylethylenediamine. Compounds (-)-3 and (+)-3 were converted into d- and l-2,3-trans-3,4-cis-4,5-trans-N-(tert-butoxycarbonyl)-5-hydroxymethyl-3,4-isopropylidenedioxyprolines (-)-4 and (+)-4, respectively. Applying the Boc and Fmoc strategies of peptide synthesis, these compounds were used to construct two tripeptides containing the d- or l-2,3-trans-3,4-cis-4,5-trans-3,4-dihydroxy-5-hydroxymethylproline.lld:pubmed
pubmed-article:15202906pubmed:languageenglld:pubmed
pubmed-article:15202906pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15202906pubmed:citationSubsetIMlld:pubmed
pubmed-article:15202906pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15202906pubmed:statusMEDLINElld:pubmed
pubmed-article:15202906pubmed:monthJunlld:pubmed
pubmed-article:15202906pubmed:issn0022-3263lld:pubmed
pubmed-article:15202906pubmed:authorpubmed-author:VogelPierrePlld:pubmed
pubmed-article:15202906pubmed:authorpubmed-author:RobinaInmacul...lld:pubmed
pubmed-article:15202906pubmed:authorpubmed-author:Moreno-Vargas...lld:pubmed
pubmed-article:15202906pubmed:authorpubmed-author:PetricciElena...lld:pubmed
pubmed-article:15202906pubmed:issnTypePrintlld:pubmed
pubmed-article:15202906pubmed:day25lld:pubmed
pubmed-article:15202906pubmed:volume69lld:pubmed
pubmed-article:15202906pubmed:ownerNLMlld:pubmed
pubmed-article:15202906pubmed:authorsCompleteYlld:pubmed
pubmed-article:15202906pubmed:pagination4487-91lld:pubmed
pubmed-article:15202906pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15202906pubmed:meshHeadingpubmed-meshheading:15202906...lld:pubmed
pubmed-article:15202906pubmed:meshHeadingpubmed-meshheading:15202906...lld:pubmed
pubmed-article:15202906pubmed:meshHeadingpubmed-meshheading:15202906...lld:pubmed
pubmed-article:15202906pubmed:year2004lld:pubmed
pubmed-article:15202906pubmed:articleTitleSynthesis of d- and l-2,3-trans-3,4-cis-4,5-trans-3,4-dihydroxy-5-hydroxymethylproline and tripeptides containing them.lld:pubmed
pubmed-article:15202906pubmed:affiliationLaboratoire de Glycochimie et de Synthèse Asymétrique, Swiss Federal Institute of Technology (EPFL), BCH, CH-1015 Lausanne-Dorigny, Switzerland. ajmoreno@us.eslld:pubmed
pubmed-article:15202906pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15202906pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed